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Original article
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Abstract – Bartonella henselae is the main agent of cat scratch disease in humans and domestic cats
are the main reservoir of this bacterium. We conducted a serosurvey to investigate the role of
American wild felids as a potential reservoir of Bartonella species. A total of 479 samples (439 serum
samples and 40 Nobuto strips) collected between 1984 and 1999 from pumas (Felis concolor) and
91 samples (58 serum samples and 33 Nobuto strips) collected from bobcats (Lynx rufus) in North
America, Central America and South America were screened for B. henselae antibodies. The overall
prevalence of B. henselae antibodies was respectively 19.4% in pumas and 23.1% in bobcats, with
regional variations. In the USA, pumas from the southwestern states were more likely to be
seropositive for B. henselae (prevalence ratio (PR) = 2.82, 95% confidence interval (CI) = 1.55, 5.11)
than pumas from the Northwest and Mountain states. Similarly, adults were more likely to be
B. henselae seropositive than juveniles and kittens (PR = 1.77, 95% CI = 1.07, 2.93). Adult pumas
were more likely to have higher B. henselae antibody titers than juveniles and kittens (p = 0.026).
B. henselae antibody prevalence was 22.4% (19/85) in bobcats from the USA and 33.3% (2/6) in
the Mexican bobcats. In the USA, antibody prevalence varied depending on the geographical origin
of the bobcats. In California, the highest prevalence was in bobcats from the coastal range (37.5%).
These results suggest a potential role of wild felids in the epidemiological cycle of Bartonella
henselae or closely related Bartonella species.
Bartonella henselae / bobcat / Felis concolor / Lynx rufus / puma
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1. INTRODUCTION
Bartonella henselae is the main agent of
cat scratch disease [4, 7]. The initial isolation of B. henselae from the blood of a cat
was reported in 1992 [18]. Since then, a
high percentage of domestic cats was found
to be bacteremic with B. henselae in various parts of the world, with some cats being
bacteremic for months [5, 13, 15]. Cats are
the main reservoir for B. henselae [1, 5,
13], and transmission is mainly from cat to
cat by cat fleas (Ctenocephalides felis) [6,
9, 11]. Cats are also the main reservoir for
B. clarridgeiae [10, 16], a more recently
discovered Bartonella species, which may
also be one of the etiologic agents of CSD
[14]. Finally, B. koehlerae has also been
isolated from two cats in California [8] and
one French cat [20] and identified by PCR
in cat fleas in France [21], but its pathogenic role in CSD is still unknown [8].
Serosurveys for the presence of Bartonella antibodies in domestic cat populations, using an immunofluorescence antibody
test, have been conducted in many parts of
the world [4], including the United States,
where an overall B. henselae antibody prevalence of respectively 27.9% among 628 pet
cats from all over North America and
28.2% of 1 314 cats from the USA was
reported [3, 12]. In California, 81% of
205 cats were found positive for B. henselae antibody [5]. In the Americas, presence
of B. henselae antibodies in domestic cats
has also been reported from Canada and
Chile [12, 17, 25]. In Chile, 54 (71.0%) of
the 76 cats tested were B. henselae antibody
positive [25].
A sero-epidemiological study of B. henselae infection in free-ranging and captive
wild felids was conducted a few years
ago in California [24]. Fifty-three percent
of 62 free-ranging bobcats (Lynx rufus) and
35% of 74 free-ranging pumas (Felis concolor) trapped in California were seropositive for B. henselae, and 30% of 114 captive

wild felids (genera Acinonyx, Panthera and
Felis) had B. henselae antibodies. Furthermore, isolation of Bartonella from freeranging pumas and bobcats from northern
California has been reported [2]. These
Bartonella spp. were experimentally infective for domestic cats [23]. Speciation of
these isolates is being presently performed.
In Florida panthers (Felis concolor coryi)
and pumas (Felis concolor stanleyana)
introduced from Texas to Florida for genetic
restoration, Rotstein et al. [22] reported a
B. henselae antibody prevalence of 18%
(5/28) in Florida panthers and of 28% (2/7)
in pumas. Besides these states, no data are
available concerning the prevalence of
B. henselae antibodies among wild felids
from other parts of North America as well
as Central and South America.
Pumas are currently found in most of
South and Central America and in the
western part of North America, as far north
as southern Alaska, and in Florida. In Florida, pumas, also known as Florida panthers, belong to a subspecies of pumas,
which is genetically distinct from other
puma subspecies, consistent with a long
period of isolation and inbreeding [19].
Bobcats are smaller felids that are quite
abundant in North and Central America.
Bartonella henselae is a potentially transmissible infectious agent among domestic
cats and wild felids [23]. Furthermore,
B. henselae is a major zoonotic agent in
humans. Therefore, it is important to investigate the presence of this infectious agent
in wild cats to determine if wild felids
could be a source of infection for domestic
animals and humans, and serve as a potential reservoir for this bacterium. The objectives of this study were: (1) to investigate
B. henselae seropositivity among American pumas and bobcats; and (2) to establish
possible risk factors (genus, species, age,
and geographical origin) associated with
Bartonella seropositivity in these wild felids.

Bartonella antibodies in pumas and bobcats

2. MATERIALS AND METHODS
2.1. Animals and serum samples
Serum samples or Nobuto filter strips
(Advantec/MSS Inc., Pleasanton, California, USA) from 479 free-ranging and captive pumas and 91 free-ranging and captive
bobcats were obtained from eight different
sources, listed as follows: (1) the National
Institutes of Health, Laboratory of Genomic
Diversity, National Cancer Institute, Frederick, MD, USA; (2) the California Department of Fish and Game, Rancho Cordova,
CA, USA; (3) University of California
Davis, School of Veterinary Medicine,
Wildlife Health Center, Davis, CA, USA;
(4) the Hornocker Wildlife Research Institute, Moscow, ID, USA; (5) the Safari
Game Search Foundation Inc., Wiston, OR,
USA; (6) the Center for Disease Control
and Prevention (CDC), National Center for
Infectious Diseases, Division of VectorBorne Infectious Diseases, Fort Collins,
CO, USA; and (7) the Idaho State University, Biological Sciences Department, Pocatello, ID, USA. Samples were collected
from 1984 through 1999 and serum samples
stored at –20 °C until tested. There were
439 serum samples and 40 Nobuto strips
from pumas, and 58 serum samples and
33 Nobuto strips from bobcats. Seventyfive percent of the serum samples (361/479)
and all forty Nobuto strips collected from
pumas were from the United States. A total
of 137 pumas (97 serum samples and
40 Nobuto strips) and 48 bobcats (15 serum
samples and 33 Nobuto strips) were from
California. The 73 Nobuto strips used in
this study were from pumas or bobcats
trapped in California for the plague surveillance program. Country of origin, county of
origin from California, estimated age, and
sex were available for most of these animals.
The serum and nobuto samples from
pumas were collected in 15 different countries: Argentina (n = 25), Belize (n = 1),
Bolivia (n = 5), Brazil (States of Sao Paulo,
Goias and Tocantinas) (n = 11), Canada
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(British Columbia) (n = 23), Chile (n = 10),
Costa Rica (n = 5), Guatemala (n = 4), Mexico (n = 12), Nicaragua (n = 5), Panama (n =
3), Paraguay (n = 3), Peru (n = 5), USA (n =
361) and Venezuela (n = 6). Within the
USA, pumas were trapped in ten different
states: Arizona (n = 15), California (n =
137), Colorado (n = 4), Florida (n = 37),
Idaho (n = 57), New Mexico (n = 7), Oregon
(n = 11), Texas (n = 40), Utah (n = 2), and
Wyoming (n = 51) (Tab. I). The bobcats
were trapped in the USA (n = 85) and Mexico (n = 6). Within the USA, bobcats were
trapped in four different states, including
California (n = 48), Florida (n = 28),
Nevada (n = 6) and Oregon (n = 3). All
puma and bobcat serum samples from Central (including Mexico) and South Americas, with the exception of three puma serum
samples from Chile, were from captive animals.
2.2. Bartonella antibody testing
Antibody titers against B. henselae
were determined using an indirect immunofluorescence antibody (IFA) as previously
described [1, 5]. Bartonella henselae (Strain
U4; University of California, Davis, USA),
originally isolated from a naturally infected
cat, was cultivated with Felis catus whole
fetus (FCWF) cells in complete cell media
for 3 to 5 days for antigen preparation. Forty
microliters of antigen solution was applied
into each well of twelve well polytetrafluoroethylene-coated slides (Cel-Line Associates, Newfield, NJ, USA), and these slides
were incubated for 24 h to allow the cells
to adhere to the slides. Slides were then
rinsed with phosphate-buffered saline
(PBS; Sigma Diagnostic St. Louis, MO,
USA, pH 7.4), air-dried, acetone fixed,
and stored at –20 °C until they were used.
Serum samples were diluted in PBS at 1:32
dilution, and any sample with a titer superior or equal to 1:64 (positive cut-off) sample was run serially at a two-fold dilution to
the end point titer. Positive control (cats
infected with Strain U4; University of California, Davis, USA) and negative control
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Table I. Prevalence of Bartonella henselae antibodies in free-ranging and captive pumas and freeranging bobcats in different countries from the Americas.
Pumas
Number of positive/
Number samples tested (%)

Bobcats
Number of positive/
Number samples tested (%)

73/361 (20.2)

19/85 (22.4)

0/23 (0.0)

N. A.

1/12 (8.3)

2/6 (33.3)

Venezuela

8/24 (33.3)

N. A.

Southern part of South Americab

11/49 (22.4)

N. A.

Geographic region

USA
Canada
Mexico
Central

Andean
Total

Americaa and
countriesc

0/10 (0.0)

N. A.

93/479 (19.4)

21/91 (23.1)

a Central America includes the five following countries: Belize, Guatemala, Panama, Costa-Rica and
Nicaragua.
b Southern Part of South America includes the four following countries: Argentina, Brazil, Paraguay and
Chile.
c Andean Countries includes the following two countries: Bolivia and Peru.
N. A.: Not applicable.

serum (SPF cats) were used for each IFA
slide. The slides were incubated for 25 min
at 37 °C and were washed for 5 min twice
with PBS. Fluorescein-conjugated goat
anti-cat immunoglobulin (Whole-molecule
immunoglobulin G; Cappel, Oreganon
Teknika Corp., Durham, NC, USA) was
diluted to 1:800 in PBS with 0.001% of
Evan’s blue. Thirty microliters of this conjugate was applied to each well, and slides
were incubated for 30 min at 37 °C and
washed with PBS for 5 min twice. Using a
fluorescence microscope (magnification,
× 400), the intensity of bacillus-specific
fluorescence was scored subjectively from
1 to 4. Fluorescence score of ≥ 2 at dilution
1:64 was considered to be a positive result.
The same two persons read all the IFA
slides independently and the endpoint titer
was the highest dilution found with a score
≥ 2 by both readers. Testing was performed
only against a B. henselae antigen, as serological testing of several puma and bobcat
serum samples by IFA with a puma strain
gave similar antibody titers when compared

to B. henselae IFA slides (Chomel, unpublished data).
Nobuto filter strips, which had been
dipped in the animal blood and air dried,
were cut thin into two equal pieces into a
1.5 mL Eppendorf vial and 0.4 mL of
borate buffer (1.5 M NaCl, 0.5 M H3BO3,
1 M NaOH), pH 8.0 added. The vial was
kept overnight at 4 °C and then heat-inactivated for 20 min at 60 °C. The paper strips
were pressed with a wood rod and removed
then two drops of washed sheep blood cells
were added. These vials were left over
night at 4 °C. The vials were centrifuged for
5 min at 2 000 rpm. These vials were kept
frozen at –20 °C until tested. The supernatant was used for IFA serology testing. We
have previously demonstrated that a dilution at 1:8 of Nobuto extracts was equivalent to a 1:64 dilution for serum samples
[24].
Data were entered in an Excel spreadsheet and analyzed using SAS 6.12 and Epi
Info 6.04b softwares. Prevalence differences were analyzed using Chi-square tests

Bartonella antibodies in pumas and bobcats
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Table II. Distribution of Bartonella henselae antibody titers among pumas from the Americas by
age group and percent positive (≥ 64) by age group.
B. henselae antibody titers
Age group

0

32

64

128

256

512

1024

Total (%)

3
2
0
0
5

67/281 (23.8)
15/100 (15)
1/19 (5.3)
10/79 (12.7)
93/479 (19.4)

Number of pumas
Adult
Juvenile
Kitten
Unknown
Total

212
84
18
69
383

2
1
0
0
3

43
6
1
8
58

11
3
0
0
14

for two by two or r by k tables. For comparison of antibody titers and age in pumas,
adults and non-adults (juveniles and kittens) were compared for three variables:
negative (titer < 64), positive (titers of 64
to 128 for B. henselae) and strong positive
(≥ 256 for B. henselae).

3. RESULTS
A total of 479 puma samples (439 serum
and 40 Nobuto strips) collected from North
America, Central America and South
America were screened for antibodies for
Bartonella henselae. The age distribution
of the animals ranged from 1 month to
> 16 years. Among the pumas for which an
estimated age was available (83.5%, 400/
479), the majority (70.2%) were adults
(≥ 24 months), 25% (n = 100) were juveniles (6 months to less than 24 months) and
4.8% of them (n = 19) were kittens
(< 6 months). Fifty-two percent (244/469)
of the pumas and 59 percent (50/85) of the
bobcats were males (sex data were missing
for 10 pumas and 6 bobcats). The overall
prevalence of Bartonella henselae antibodies in pumas was 19.4%, and ranged from
0% in Canada, Bolivia and Peru to 33.3%
in Central America and Venezuela (Tab. I).
Antibody titers of positive animals ranged
from 64 to 1 024, most (78.3%) of the positive pumas having low titers (64 or 128)

8
4
0
2
14

2
0
0
0
2

(Tab. II). There was no statistical difference between the prevalence of B. henselae
antibodies in the various geographical
regions (North, Central and South) of the
Americas.
Among the 361 puma samples (321 serum
samples and 40 Nobuto strips) collected in
the United States and tested for B. henselae, 73 (20.2%) were seropositive. Antibody prevalence for B. henselae varied
widely among the various geographic locations where the samples were collected
(Tab. III). More specifically, pumas from
the Southwestern states (Arizona, California, and New Mexico) were almost three
times more likely to be seropositive for
B. henselae than pumas from the Northwestern and Mountain states (Colorado,
Idaho, Oregon, Utah, Wyoming) (Prevalence ratio (PR) = 2.82, 95% Confidence
Interval (CI) = 1.55, 5.11).
In California, antibodies to B. henselae
were found in 28.5% of the 137 pumas
tested (Tab. IV). In that state, young pumas
(juveniles and kittens) had higher antibody
prevalence (36.7%, 11/30) than adults
(25.2%, 25/99). In Florida, none of the
18 juvenile panthers had Bartonella antibodies. Prevalence of B. henselae antibodies in pumas was not statistically different
among the various geographic regions of
California (Tab. IV).
Overall, antibody prevalence for B. henselae increased with age in pumas (Tab. II).
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Table III. Prevalence of Bartonella henselae
antibodies in free-ranging pumas and bobcats
from different states of the USA.
States

Arizona
California

Pumas
P/N (%)a

Bobcats
P/N (%)

4/15 (26.7)

N. A.b

39/137 (28.5)

14/48 (29.2)

Colorado

0/4 (0.0)

N. A.

Florida

2/37 (5.4)

3/28 (10.7)

Idaho

5/57 (8.8)

N. A.

N. A.

1/6 (16.7)

0/7 (0.0)

N. A.

Nevada
New Mexico
Oregon
Texas

1/11 (9.1)

1/3 (33.3)

16/40 (40.0)

N. A.

Utah
Wyoming
Total

0/2 (0.0)

N. A.

6/51 (11.8)

N. A.

73/361 (20.2)

19/85 (22.4)

a Number of positive samples/number of samples

tested (percent).
N. A.: Not applicable.

b

Sixty-seven (23.8%) of the 281 adults were
seropositive for B. henselae, whereas only
15% of the 100 juveniles and 5.3% of the
19 kittens were seropositive. Adult pumas
were 1.77 times (95% CI = 1.07, 2.93) more
likely to have B. henselae antibodies than
juveniles and kittens. Adult pumas were
also more likely to have higher B. henselae
antibody titers than juveniles and kittens
(p = 0.026). Similar associations were identified for pumas from the USA, where
adults were two times more likely to be
B. henselae seropositive than juveniles and
kittens (PR = 2.06, 95% CI = 1.15, 3.68).
They were also more likely to have higher
B. henselae antibody titers (p = 0.005).
None of the juveniles from Texas (0/4) or
Florida (0/18) had Bartonella antibodies,
whereas 44.4% (16/36) and 11.1% (2/18) of
the adults were seropositive. There were no
prevalence differences by sex for B. henselae antibodies, as 20.9% (51/244) of the
males and 17.3% (39/225) of the females
were seropositive.
A total of 91 bobcat samples (58 serum
samples and 33 Nobuto strips) were tested

Table IV. Prevalence of Bartonella henselae antibodies in free-ranging pumas and bobcats from
different regions of California.
Pumas
P/N (%)a

Bobcats
P/N (%)

Coastal Rangeb
Sierra Nevadac
Central Valleyd
Southern Californiae
Unknown

10/61 (16.4)
17/52 (32.7)
0/5 (0.0)
10/14 (71.4)
2/5 (0.4)

12/32 (37.5)
1/9 (11.1)
0/3 (0)
1/4 (25)
N. A.

Total

39/137 (28.5)

14/48 (29.2)

Geographic region

a Number of positive samples/number of samples tested (percent).
b Coastal Range includes the 18 following counties: Alameda, Contra Costa, Del Norte, Humboldt, Lake,

Marin, Mendocino, Monterey, Napa, San Benito, San Luis Obispo, San Mateo, Santa Barbara, Santa
Clara, Santa Cruz, Siskiyou, Sonoma, Trinity.
Nevada includes the 16 following counties: Amador, Butte, Calaveras, El Dorado, Inyo, Lassen,
Mariposa, Modoc, Mono, Nevada, Placer, Plumas, Shasta, Sierra, Tuolumne, Yuba.
d Central Valley includes the 15 following counties: Colusa, Fresno, Glenn, Kings, Kern, Sacramento,
San Joaquin, Solano, Stanislaus, Sutter, Madera, Merced, Tehama, Tulare, Yolo.
e Southern California includes the 7 following counties: Imperial, Los Angeles, Orange, Riverside, San
Bernardino, San Diego, Ventura.
c Sierra

Bartonella antibodies in pumas and bobcats

for B. henselae antibodies. All but six samples (from Mexico) were from the USA.
Bartonella henselae antibody prevalence
was 22.4% (19/85) in bobcats from the
USA and 33.3% (2/6) in the Mexican bobcats (Tab. I). In the USA, antibody prevalence varied from 10.7% in Florida to
33.3% in Oregon, depending on the geographical origin of the bobcats (Tab. III). In
California, the highest prevalence was in
bobcats from the coastal range (37.5%)
whereas none of the three bobcats captured
in the central valley region were seropositive (Tab. IV). In Santa Clara County, 9
(56%) of 16 bobcats were seropositive,
whereas none of the 7 bobcats from Mendocino County had Bartonella antibodies.
The only bobcat from Marin County was
seropositive. No sex differences in B. henselae antibody prevalence were observed
between males (22%, 11/50) and females
(26%, 9/35). Among the 60 bobcats for
which an age was given, 92% (55/60) were
adults. Antibody prevalence was 32.7%
(18/55) in adult bobcats, whereas none of
the five juveniles had B. henselae antibody.
4. DISCUSSION
This study confirms the previous reports
of Bartonella antibodies in Californian
pumas and bobcats [24] and Florida panthers [22], and extends the known distribution of this infection throughout most of
the geographical range of these wild felids.
It is the first report of Bartonella antibodies in free-ranging and captive pumas and
bobcats from various parts of North, Central and South America. Antibody prevalence varied depending upon the origin of
the animals within their natural geographic
range. Overall, there was no statistical difference between the prevalence of B. henselae antibodies in pumas from the three
main geographical regions (North, Central,
and South) of the Americas.
Within the United States, overall prevalence (20.2%) of B. henselae antibodies
from free-ranging pumas was close to the
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prevalence previously reported in domestic
cats (27% to 28%) [3, 12]. With the exception of Florida, where the puma population
is endangered, wild cats from the warm,
southern states (such as Arizona, California
and Texas) had a higher seroprevalence
than animals from the mountainous or more
northern states (such as Colorado, Idaho,
Utah, Wyoming and Oregon). This distribution superposes well with the reported
distribution of Bartonella infection in
domestic cats [12], and also fits with the
known distribution of the main vectors
of Bartonella spp., especially fleas, as
reported for domestic cats [6, 12, 13]. In
free-ranging pumas from California, we
found a seroprevalence of 28.5%, which is
close to the 35% previously reported for
74 free-ranging California pumas [24]. We
found a higher Bartonella antibody prevalence in pumas from Texas (40%, 16/40)
than the prevalence of 28% (2/7) reported
by Rotstein et al. [22]. Such a difference is
likely related to a random sampling error,
despite a slightly larger sample size in our
study. Similarly, the time of collection of
samples varied between studies and may
have led to differences in prevalence of
infection. On the contrary, we found a much
lower prevalence (5.4%, 2/37) in Florida
panthers than the 18% (5/28) reported by
Rotstein et al. [22], especially when comparing juvenile pumas. In our study, none
of the 18 juveniles tested had Bartonella
antibodies, whereas 40% (4/10) were positive in Rotstein et al.’s study [22]. Continuing surveillance of Bartonella antibodies
in Florida panthers will be necessary to
determine if infection is spreading among
these animals. The Bartonella antibody
prevalence for California bobcats in our
study was somehow lower (29.2%, 14/48)
than previously reported (53%, 33/62) [24].
This difference may be attributable to the
geographical origin of our respective bobcat populations. The majority of our bobcat
samples were collected from the Central
and South coast of California (24/48),
whereas in the previous study, 39% of the
bobcat samples were collected from the
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North coast of California (24/62). Interestingly, none of the seven bobcats from Mendocino County in this study and none of the
seven bobcats from the same county in the
previous study were seropositive [24]. Similarly, seroprevalence was almost identical
for bobcats from Santa Clara County (56%
(9/16) in this study compared to 53% (10/
19) in the previous study).
Overall, B. henselae antibody prevalence in pumas increased with age, which
can be explained by a regular exposure to
the infectious agent with time. This observation was also supported by higher antibody titers in adults than in young
(juveniles and kittens) pumas. Only one kitten was seropositive (titer of 64), and only
two juvenile pumas had antibody titers
> 256 versus five adults. However, in California, a higher prevalence in young freeranging pumas was observed, as previously
reported [24]. The antibody prevalence in
young pumas was also very similar (36.7%
compared to 40%) in both studies. Such a
difference for California warrants further
investigation. As previously reported [22,
24], no difference in Bartonella antibody
prevalence by gender was observed.
The results of the present study indicate
the presence of Bartonella antibodies in
wild felids in the Americas. It will be important to determine if such felids are reservoirs of Bartonella species that are restricted
to their own species. Further studies will
be necessary to determine the dynamics of
Bartonella infection within the puma and
bobcat populations and the possible transmission of Bartonella spp. from wild felids
to domestic cats or from the domestic reservoir to wildlife. Similarly, it will be important to determine if the vectors involved
in the transmission of Bartonella in wild
felids are similar or different from the ones
involved in the Bartonella transmission
among domestic cats.
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